Joseph Edelman

Last updated

Joseph Edelman
Born1955 (age 68–69)
Alma mater BS, Psychology, 1978, University of California, San Diego
MBA, New York University Stern School of Business, 1988
OccupationHedge fund manager
Known forBiotechnology investments
Edelman Family Foundation
Board member of Brown University
New York Genome Center
Athira Pharma
SpouseSusan "Suzy" Lebovitz-Edelman
Parent Isidore Edelman

Joseph Edelman (born 1955) is an American hedge fund manager who founded Perceptive Advisors, a New York City-based hedge fund specializing in the healthcare sector and biotechnology. [1] He helped take biotech firms public via the use of special-purpose acquisition companies.

Contents

Early life and education

Edelman's father, Isidore Edelman, was a scientist who became a professor emeritus of biochemistry and molecular biophysics at Columbia's College of Physicians and Surgeons. [2] Edelman was the third of four children and grew up in San Francisco. [3] [4] [5]

Edelman graduated magna cum laude with a degree in Psychology from the University of California, San Diego in 1978. [6] [7] Subsequently, he enrolled in graduate studies in pharmacology but left the program upon realizing that he sought a different career path than that of his father. [4]

Drawn to the finance sector, he relocated to New York City, where he obtained his MBA from New York University's Stern School of Business in 1988. [1] [4] To support himself during his studies, he worked in accounting, including his role as assistant comptroller for the Actors' Equity Association. [4]

Career

Edelman began his career in 1987 as a biotechnology analyst at brokerage Wall Street Labe, Simpson & Company before moving to Prudential Securities as senior biotech analyst in 1990. [2] In 1994, Edelman joined Paramount Capital Asset Management, running The Aries Funds until 1998. [5] He joined First New York Securities in February 1999, a proprietary trading firm that allocated $6 million for him to manage an account. [4]

In July 1999, Edelman founded Perceptive Advisors, a hedge fund firm focused on identifying and investing in promising technologies and innovations in the field of biotechnology. [4] [1] The firm began with $6 million in assets and grew to $4.1 billion by 2018. [4] By 2018, its flagship hedge fund, the Perceptive Life Sciences Fund, had delivered annualized gains of 30 percent net of fees since its inception. [4]

Edelman's firm's assets further grew to $8 billion in April 2023 and $10 billion in July that year. [8] [9] In addition to Perceptive Life Sciences, he has invested in small and mid-cap biotech firms such as CymaBay Therapeutics and Cerevel Therapeutics. [8]

Edelman played a significant role in the establishment of ARYA Sciences Acquisition Corp I, II, III, IV, and V. [10] [11] [12] The special purpose acquisition companies (SPACs) were created to facilitate mergers, acquisitions, and public listings for companies in the biotechnology, pharmaceutical, and healthcare industries. [11] In 2022, Perceptive settled charges with the U.S. Securities and Exchange Commission (SEC), accepting a censure and paying a $1.5 million fine. The SEC claimed that the firm had failed to disclose to investors that the firm's employees had stakes in the SPACs the investors were directed to. [13]

Edelman is on the board of trustees at Brown University and the boards of directors at the New York Genome Center, Athira Pharma, and Xontogeny, a support firm for early-stage life science companies. [14] [15] [16]

Edelman Family Foundation

He established the Edelman Family Foundation. [17] According to an investigation by the Huffington Post, the foundation was the primary funder enabling the creation of Do No Harm, an advocacy group that opposes anti-racism education in public schools and gender-affirming care for minors; the donation is characterized by the Foundation in its IRS filing as "to provide support to protect healthcare from a radical, divisive, and discriminatory ideology." [18] [19] [20] Other recipients of Foundation funds include the Cato Institute, the Foundation Against Intolerance and Racism, the Foundation for Individual Rights and Expression, the Manhattan Institute (funds, according to tax filings, intended to support a “gender identity initiative”), Parents Defending Education, PragerU, and unaccredited university UATX. The Foundation stopped providing funding to the Center for Reproductive Rights due to what the Foundation described as the Center's "adoption of gender ideology". [19]

Personal life

He is married to Susan "Suzy" Lebovitz-Edelman, who is co-chair of the Edelman Family Foundation. [19] She was educated at Princeton Day School, and earned a bachelor's degree from Brown University. [21]

In 2021, they bought an 18,000 square foot oceanfront mansion in a gated community in Laguna Beach, California for US$70 million, a record for Orange County. [22]

Related Research Articles

A special purpose acquisition company, also known as a "blank check company", is a shell corporation listed on a stock exchange with the purpose of acquiring a private company, thus making the private company public without going through the initial public offering process, which often carries significant procedural and regulatory burdens. According to the U.S. Securities and Exchange Commission (SEC), SPACs are created specifically to pool funds to finance a future merger or acquisition opportunity within a set timeframe; these opportunities usually have yet to be identified while raising funds.

Khosla Ventures is an American venture capital firm founded by Vinod Khosla, focused on early-stage companies in the Internet, computing, mobile, financial services, agriculture, healthcare and clean technology sectors. Some of its most successful investments include Affirm, DoorDash, Square, Impossible Foods, Instacart, and OpenAI.

John Alfred Paulson is an American billionaire hedge fund manager. He leads Paulson & Co., a New York–based investment management firm he founded in 1994. He has been called "one of the most prominent names in high finance", and "a man who made one of the biggest fortunes in Wall Street history."

<span class="mw-page-title-main">Patrick Soon-Shiong</span> South African billionaire physician, CEO & philanthropist (b. 1952)

Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

Leon G. Cooperman is an American billionaire investor and hedge fund manager. He is the chairman and CEO of Omega Advisors, a New York-based investment advisory firm managing over $3.3 billion in assets under management, the majority consisting of his personal wealth.

Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the U.S. Atlas is headquartered in Cambridge, Massachusetts, where the majority of its investments are located. Atlas raised its thirteenth fund totaling $450 million in March 2022, after raising its Opportunity Fund II totaling $300 million in September 2021.

Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.

<span class="mw-page-title-main">Chamath Palihapitiya</span> Sri Lankan-born businessman

Chamath Palihapitiya is a Sri Lankan-born Canadian and American venture capitalist, engineer, SPAC sponsor, founder and CEO of Social Capital. Palihapitiya was an early senior executive at Facebook, working at the company from 2007 to 2011. Following his departure from Facebook, Palihapitiya started The Social+Capital Partnership, through which he invested in several companies, including Yammer and Slack. He is a co-host of a technology podcast, All In, along with David Sacks, Jason Calacanis, and David Friedberg.

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.

Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.

Abingworth LLP is a transatlantic bioscience investment firm founded in 1973 by a pair of London stockbrokers, Peter Dicks and Hon. Anthony Montagu. Abingworth had initially sought to extend its investments into the biotechnology industry in the late 1980s, and has subsequently been investing in life science and healthcare services companies since at least 2001, and had expanded to include information technology firm investments by 2016.

Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Remy White Trafelet is an American hedge fund manager and investor. He is the president and CEO of investment firm Trafelet & Company, LLC, and Chairman of Hazeltree Treasury Solutions, a company Trafelet founded in 2011.

<span class="mw-page-title-main">OrbiMed</span> American investment firm

OrbiMed is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered one of the world's largest dedicated healthcare investment firms.

Trump Media & Technology Group Corp. (TMTG) is an American media and technology company majority-owned by former U.S. president Donald Trump. Founded by Andy Litinsky and Wes Moss in 2021, it became a public company on March 26, 2024 after merging with Digital World Acquisition Corp. (DWAC), a special-purpose acquisition company. The company is based in Sarasota, Florida.

Deerfield Management ("Deerfield") is an American investment firm headquartered in New York City. It is focused on making public and private investments in the healthcare and biotechnology industries. Deerfield is considered to be one of the largest dedicated healthcare investment firms in the world.

<span class="mw-page-title-main">Perceptive Advisors</span> Healthcare investment firm in New York

Perceptive Advisors ("Perceptive") is an American investment firm headquartered in New York City. It is focused on making public and private investments in the healthcare and biotechnology industries.

<span class="mw-page-title-main">RA Capital Management</span> Healthcare investment firm in Boston

RA Capital Management is an American investment firm based in Boston. It is focused on making public and private investments in the Healthcare and Biotechnology industries.

Versant Ventures ("Versant") is an American Venture capital firm headquartered in San Francisco, California. It is focused on making investments in the healthcare and biotechnology industries.

References

  1. 1 2 3 "Joseph Edelman". Forbes. Retrieved March 6, 2018.
  2. 1 2 Crowe, Portia. "A hedge fund manager you've never heard of made $300 million last year". Business Insider. Archived from the original on August 17, 2018. Retrieved August 17, 2018.
  3. ↑ Pearce, Jeremy (December 2, 2004). "Isidore Edelman, 84, Columbia Scientist Who Led Genome Center, Dies". New York Times .
  4. 1 2 3 4 5 6 7 8 "The 41% Man". Institutional Investor. August 13, 2018. Retrieved March 11, 2024.
  5. 1 2 Vardi, Nathan. "A Sixth Sense For Biotech Has Made Joe Edelman A Hedge Fund Star". Forbes. Retrieved March 11, 2024.
  6. ↑ Roche, Julia La. "This hedge fund crushed the competition in 2015". Business Insider. Retrieved March 11, 2024.
  7. ↑ "UC San Diego Alumnus Joseph Edelman Pledges $400,000 to Help Students Facing Mental Health Challenge". today.ucsd.edu. Retrieved March 11, 2024.
  8. 1 2 "Billionaire Joseph Edelman Snaps Up These 2 Biotech Stocks — Here's Why You Should Follow". Yahoo Finance. April 26, 2023. Retrieved March 13, 2024.
  9. ↑ "OC's Wealthiest 2023: Joseph Edelman". Orange County Business Journal. July 25, 2023. Retrieved March 13, 2024.
  10. ↑ "Joseph Edelman: Positions, Relations and Network - MarketScreener". www.marketscreener.com. Retrieved March 11, 2024.
  11. 1 2 "Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development - Cerevel Therapeutics". www.cerevel.com. July 30, 2020. Retrieved March 11, 2024.
  12. ↑ "Perceptive Keeps SPAC Frenzy Going". Institutional Investor. February 12, 2021. Retrieved March 11, 2024.
  13. ↑ Alpert, Lukas I. (September 6, 2022). "Billionaire Joe Edelman's biotech hedge fund hit with SEC charges for not disclosing SPAC conflicts". Market Watch. Retrieved March 14, 2024.
  14. ↑ "Joseph Edelman". Perceptive Advisors. Retrieved March 11, 2024.
  15. ↑ "Joseph E. Edelman". Corporation | Brown University. Retrieved March 11, 2024.
  16. ↑ "Who We Are - Xontogeny" . Retrieved March 11, 2024.
  17. ↑ "Edelman Family Foundation". Edelman Family Foundation. Retrieved March 13, 2024.
  18. ↑ Chudy, Emily (October 30, 2023). "Billionaire Joseph Edelman accused of 'quietly financing' America's anti-trans movement". Pink News . Retrieved February 8, 2024.
  19. 1 2 3 "The Billionaire Secretly Funding Anti-Trans Advocacy Across The U.S." HuffPost. October 26, 2023. Retrieved April 1, 2024.
  20. ↑ Russell, John (December 2, 2023). "Conservatives use anti-trans hearing to promote conversion therapy over gender-affirming care". LGBTQ Nation. Retrieved April 1, 2024.
  21. ↑ "Princeton Day School Board of Trustees Welcomes Five New Members". Princeton Online. July 17, 2020. Retrieved April 3, 2024.
  22. ↑ Barrera, Sandra (November 30, 2021). "Laguna Beach mansion breaks Orange County record sale price at $70 million". Mercury News. Retrieved April 3, 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.